WHO WE ARE
Our mission is simple - support the communities we operate in, help our partners succeed and support our employees by inventing new drugs and treatments for the unmet clinical needs of the world
​
Enigma Pharma PLC is an established contract development and manufacturing organisation providing an extensive range of integrated services across the drug development lifecycle to the pharmaceutical and biotech sectors globally.
​
Our innovative services range from R&D, biomarker discovery, development and commercialisation, API manufacture, formulation development, clinical trial supply, IRT (IVRS/IWRS) through to commercial-scale manufacture.
​
We are an international company that has grown organically over the past five decades now employing over 5,600 highly skilled personnel across 8 facilities including Europe, the US and Asia.
​
We have a global reputation for excellence built over 50 years of client service, initially as Enigma and then as the wider Enigma Pharma Group including  VdH , delivering expertise right across the drug development lifecycle and offering a tailored solution to each of our clients.
Our Core Values:
​
​
QUALITY
We strive for outstanding Quality - this will drive our success and reputation
​
​
​
PEOPLE
We employ inspirational people - our people are our greatest asset and we need to empower them to be the best they can be
​
​
​
PATIENTS
We focus on our customers and patients - we are committed to understanding and exceeding the expectations of both our service customers and the patients who rely on us to support them in their lives
OUR TEAM
Edwin Gill
CEO
Edwin joined Enigma Pharma in 2019 and has over 30 years’ experience in the pharmaceutical industry. He obtained a PhD in Chemistry from Queen’s University, Belfast and is a member of the Institute of Directors. Since 2020 Edwin has been responsible for the strategic, financial and operational leadership of Clinical Services Business Unit. As well as his duties as Group CEO
Allan Lane
SVP
Alan was a Graduate Member of the Royal Society of Chemistry in 1981. He joined Galen Research Laboratories in 1978 in the quality control department where he took over as Quality Assurance Manager in 1982. Alan held a number of senior management operational and technical positions until 1995 when he was appointed to the Board of Directors 
Dominic Di Modo
VP Consumer Health
As President and Managing Director of the Consumer Health Business Unit, Domonic brings more than 20 years of experience in the Consumer Health Development industry. Since joining Enigma , Domonic has held this leadership role overseeing Consumer Project Services, and Operations where he was charged with the development and execution of the company’s long-term commercial and operational growth strategies.
Len Goodman
VP Corporate Services
Len graduated from Queen’s University, Belfast with a degree in Mathematics and Computer Science. He then qualified as a Chartered Accountant with PricewaterHouse before moving to Deloitte where he was a Director of Corporate Finance. He joined Enigma in 2011 as VP Corporate Services and oversees the move to a shared service platform supporting the growth of the business